TRIPLE 26 LTD
Company number SC674586 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
TRIPLE 26 LTD - Analysis Report
Company Number: SC674586
Analysis Date: 2025-07-29 18:00 UTC
Financial Health Assessment for TRIPLE 26 LTD
1. Financial Health Score: D
Explanation:
The company exhibits significant financial distress with persistent negative net current assets and shareholders' funds over multiple years. The working capital position is deeply negative, indicating liquidity challenges and a potential inability to meet short-term obligations without external support.
2. Key Vital Signs
| Metric | 2023 Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 20,654 | Small investment in long-term assets, stable but modest. |
| Current Assets | 12,632 | Limited short-term resources available to cover liabilities. |
| Current Liabilities | 68,579 | High short-term debts due within one year, significantly exceeding current assets. |
| Net Current Assets | -55,947 | Negative working capital indicates liquidity strain ("symptom of distress"). |
| Total Assets Less Current Liabilities | -35,293 | Negative net assets signaling insolvency on a balance sheet basis. |
| Shareholders’ Funds | -35,293 | Negative equity suggests accumulated losses and capital erosion ("underlying disease"). |
| Average Number of Employees | 7 | Small workforce consistent with micro/small business scale. |
| Overdue Accounts Filing | Yes | Compliance risk due to late filing, potential penalties, and reputational impact. |
3. Diagnosis
TRIPLE 26 LTD is currently in a precarious financial condition. The company’s negative net current assets over four consecutive years reveal chronic liquidity issues, meaning its short-term obligations far exceed the available short-term assets—a clear symptom of financial distress. The negative shareholders’ funds indicate accumulated losses have eroded the capital base, signaling that the company is effectively insolvent on a balance sheet perspective.
Despite continuing operations (active status), the company’s balance sheet suggests it is reliant on external financing or creditor forbearance to sustain operations. The industry sector (public houses and bars) is typically cash-flow intensive and sensitive to economic cycles, which may exacerbate financial strain if cash inflows are inconsistent.
Moreover, the company has overdue accounts filing, which is a compliance red flag and can further complicate access to finance or trade credit. The small fixed asset base and modest current assets relative to liabilities suggest limited collateral or liquid reserves.
4. Recommendations
Strengthen Liquidity:
- Negotiate extended payment terms with creditors to reduce pressure on immediate cash outflows.
- Consider short-term financing options (e.g., overdrafts, invoice factoring) to bridge working capital gaps.
Capital Injection:
- Seek equity investment or shareholder loans to restore positive net assets and provide financial breathing room.
- Explore government support or grants available to hospitality businesses.
Cost Optimization:
- Review staffing and operational expenses to identify cost savings without impairing core business functions.
- Improve inventory and cash management to optimize cash flow.
Compliance and Governance:
- File overdue accounts immediately to avoid penalties and maintain regulatory standing.
- Enhance financial reporting and forecasting to anticipate future liquidity needs and avoid surprises.
Strategic Review:
- Assess the business model and market positioning to identify growth opportunities or necessary pivots, especially considering industry volatility.
- Engage with professional advisors for restructuring advice if insolvency risk escalates.
Medical Analogy Summary:
The company is showing symptoms of financial distress, such as poor liquidity and negative equity, akin to a patient with chronic illness requiring urgent intervention. Without a treatment plan involving capital infusion, cost control, and compliance correction, the prognosis remains guarded with risk of worsening financial health.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.